NewsBenzingaImmunome Analysts Cut Their Forecasts After Q3 Results Immunome Analysts Cut Their Forecasts After Q3 Results Benzinga 2026.11.10 15:22 (GMT+0) Open on Benzinga Other news Wedbush Maintains Outperform on Viridian Therapeutics, Raises Price Target to $44 Wells Fargo Maintains Overweight on Monday.Com, Lowers Price Target to $100 Wedbush Maintains Outperform on Perspective Therapeutics, Lowers Price Target to $7 Oracle Stock Hovers Around the Flatline: What's Going On? Jupiter launches token baskets, yield vaults and other new products, expanding beyond trading Nancy Pelosi’s Warner Bros. Stake Was Cashed Out in Paramount Deal, Worth About 43% of Her Salary
